202 related articles for article (PubMed ID: 26048789)
1. Discovery of novel pyrazole-containing benzamides as potent RORγ inverse agonists.
Wang T; Banerjee D; Bohnert T; Chao J; Enyedy I; Fontenot J; Guertin K; Jones H; Lin EY; Marcotte D; Talreja T; Van Vloten K
Bioorg Med Chem Lett; 2015 Aug; 25(15):2985-90. PubMed ID: 26048789
[TBL] [Abstract][Full Text] [Related]
2. Discovery of biaryl carboxylamides as potent RORγ inverse agonists.
Chao J; Enyedy I; Van Vloten K; Marcotte D; Guertin K; Hutchings R; Powell N; Jones H; Bohnert T; Peng CC; Silvian L; Hong VS; Little K; Banerjee D; Peng L; Taveras A; Viney JL; Fontenot J
Bioorg Med Chem Lett; 2015 Aug; 25(15):2991-7. PubMed ID: 26048806
[TBL] [Abstract][Full Text] [Related]
3. Small molecule mediated inhibition of RORγ-dependent gene expression and autoimmune disease pathology in vivo.
Banerjee D; Zhao L; Wu L; Palanichamy A; Ergun A; Peng L; Quigley C; Hamann S; Dunstan R; Cullen P; Allaire N; Guertin K; Wang T; Chao J; Loh C; Fontenot JD
Immunology; 2016 Apr; 147(4):399-413. PubMed ID: 26694902
[TBL] [Abstract][Full Text] [Related]
4. Benzoxazepines Achieve Potent Suppression of IL-17 Release in Human T-Helper 17 (TH 17) Cells through an Induced-Fit Binding Mode to the Nuclear Receptor RORγ.
Olsson RI; Xue Y; von Berg S; Aagaard A; McPheat J; Hansson EL; Bernström J; Hansson P; Jirholt J; Grindebacke H; Leffler A; Chen R; Xiong Y; Ge H; Hansson TG; Narjes F
ChemMedChem; 2016 Jan; 11(2):207-16. PubMed ID: 26553345
[TBL] [Abstract][Full Text] [Related]
5. Identification of N-phenyl-2-(N-phenylphenylsulfonamido)acetamides as new RORγ inverse agonists: Virtual screening, structure-based optimization, and biological evaluation.
Song Y; Xue X; Wu X; Wang R; Xing Y; Yan W; Zhou Y; Qian CN; Zhang Y; Xu Y
Eur J Med Chem; 2016 Jun; 116():13-26. PubMed ID: 27043267
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting RORγt/Th17 axis for autoimmune disorders.
Isono F; Fujita-Sato S; Ito S
Drug Discov Today; 2014 Aug; 19(8):1205-11. PubMed ID: 24792721
[TBL] [Abstract][Full Text] [Related]
7. Discovery of N-indanyl benzamides as potent RORγt inverse agonists.
Tian J; Sun N; Yu M; Gu X; Xie Q; Shao L; Liu J; Liu L; Wang Y
Eur J Med Chem; 2019 Apr; 167():37-48. PubMed ID: 30743096
[TBL] [Abstract][Full Text] [Related]
8. RORγ antagonists and inverse agonists: a patent review.
Bronner SM; Zbieg JR; Crawford JJ
Expert Opin Ther Pat; 2017 Jan; 27(1):101-112. PubMed ID: 27629281
[TBL] [Abstract][Full Text] [Related]
9. (Inverse) Agonists of Retinoic Acid-Related Orphan Receptor γ: Regulation of Immune Responses, Inflammation, and Autoimmune Disease.
Jetten AM; Cook DN
Annu Rev Pharmacol Toxicol; 2020 Jan; 60():371-390. PubMed ID: 31386594
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel quinoline sulphonamide derivatives as potent, selective and orally active RORγ inverse agonists.
Amaudrut J; Argiriadi MA; Barth M; Breinlinger EC; Bressac D; Broqua P; Calderwood DJ; Chatar M; Cusack KP; Gauld SB; Jacquet S; Kamath RV; Kort ME; Lepais V; Luccarini JM; Masson P; Montalbetti C; Mounier L; Potin D; Poupardin O; Rouaud S; Spitzer L; Wallace CD
Bioorg Med Chem Lett; 2019 Jul; 29(14):1799-1806. PubMed ID: 31101472
[TBL] [Abstract][Full Text] [Related]
11. RORγ Structural Plasticity and Druggability.
Huang M; Bolin S; Miller H; Ng HL
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32727079
[TBL] [Abstract][Full Text] [Related]
12. Targeting Th17 cells in autoimmune diseases.
Yang J; Sundrud MS; Skepner J; Yamagata T
Trends Pharmacol Sci; 2014 Oct; 35(10):493-500. PubMed ID: 25131183
[TBL] [Abstract][Full Text] [Related]
13. Discovery and Characterization of CD12681, a Potent RORγ Inverse Agonist, Preclinical Candidate for the Topical Treatment of Psoriasis.
Ouvry G; Atrux-Tallau N; Bihl F; Bondu A; Bouix-Peter C; Carlavan I; Christin O; Cuadrado MJ; Defoin-Platel C; Deret S; Duvert D; Feret C; Forissier M; Fournier JF; Froude D; Hacini-Rachinel F; Harris CS; Hervouet C; Huguet H; Lafitte G; Luzy AP; Musicki B; Orfila D; Ozello B; Pascau C; Pascau J; Parnet V; Peluchon G; Pierre R; Piwnica D; Raffin C; Rossio P; Spiesse D; Taquet N; Thoreau E; Vatinel R; Vial E; Hennequin LF
ChemMedChem; 2018 Feb; 13(4):321-337. PubMed ID: 29327456
[TBL] [Abstract][Full Text] [Related]
14. Increasing human Th17 differentiation through activation of orphan nuclear receptor retinoid acid-related orphan receptor γ (RORγ) by a class of aryl amide compounds.
Zhang W; Zhang J; Fang L; Zhou L; Wang S; Xiang Z; Li Y; Wisely B; Zhang G; An G; Wang Y; Leung S; Zhong Z
Mol Pharmacol; 2012 Oct; 82(4):583-90. PubMed ID: 22700697
[TBL] [Abstract][Full Text] [Related]
15. Discovery of 1-{4-[3-fluoro-4-((3s,6r)-3-methyl-1,1-dioxo-6-phenyl-[1,2]thiazinan-2-ylmethyl)-phenyl]-piperazin-1-yl}-ethanone (GNE-3500): a potent, selective, and orally bioavailable retinoic acid receptor-related orphan receptor C (RORc or RORγ) inverse agonist.
Fauber BP; René O; Deng Y; DeVoss J; Eidenschenk C; Everett C; Ganguli A; Gobbi A; Hawkins J; Johnson AR; La H; Lesch J; Lockey P; Norman M; Ouyang W; Summerhill S; Wong H
J Med Chem; 2015 Jul; 58(13):5308-22. PubMed ID: 26061388
[TBL] [Abstract][Full Text] [Related]
16. Discovery of imidazo[1,5-a]pyridines and -pyrimidines as potent and selective RORc inverse agonists.
Fauber BP; Gobbi A; Robarge K; Zhou A; Barnard A; Cao J; Deng Y; Eidenschenk C; Everett C; Ganguli A; Hawkins J; Johnson AR; La H; Norman M; Salmon G; Summerhill S; Ouyang W; Tang W; Wong H
Bioorg Med Chem Lett; 2015 Aug; 25(15):2907-12. PubMed ID: 26048793
[TBL] [Abstract][Full Text] [Related]
17. Discovery of biaryls as RORγ inverse agonists by using structure-based design.
Enyedy IJ; Powell NA; Caravella J; van Vloten K; Chao J; Banerjee D; Marcotte D; Silvian L; McKenzie A; Hong VS; Fontenot JD
Bioorg Med Chem Lett; 2016 May; 26(10):2459-2463. PubMed ID: 27080181
[TBL] [Abstract][Full Text] [Related]
18. Discovery of N-(4-aryl-5-aryloxy-thiazol-2-yl)-amides as potent RORγt inverse agonists.
Wang Y; Yang T; Liu Q; Ma Y; Yang L; Zhou L; Xiang Z; Cheng Z; Lu S; Orband-Miller LA; Zhang W; Wu Q; Zhang K; Li Y; Xiang JN; Elliott JD; Leung S; Ren F; Lin X
Bioorg Med Chem; 2015 Sep; 23(17):5293-302. PubMed ID: 26277758
[TBL] [Abstract][Full Text] [Related]
19. Modulators of the nuclear receptor retinoic acid receptor-related orphan receptor-γ (RORγ or RORc).
Fauber BP; Magnuson S
J Med Chem; 2014 Jul; 57(14):5871-92. PubMed ID: 24502334
[TBL] [Abstract][Full Text] [Related]
20. Structural studies unravel the active conformation of apo RORγt nuclear receptor and a common inverse agonism of two diverse classes of RORγt inhibitors.
Li X; Anderson M; Collin D; Muegge I; Wan J; Brennan D; Kugler S; Terenzio D; Kennedy C; Lin S; Labadia ME; Cook B; Hughes R; Farrow NA
J Biol Chem; 2017 Jul; 292(28):11618-11630. PubMed ID: 28546429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
